Celltrion
068270.KS
#724
Rank
NZ$48.30 B
Marketcap
$235.70
Share price
0.05%
Change (1 day)
2.52%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Cash on Hand

Cash on Hand as of June 2024 : NZ$1.32 Billion

According to Celltrion 's latest financial reports the company has NZ$1.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celltrion - Cash on Hand chart (from 2007 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.74 B-50.53%
2021-12-31NZ$1.50 B68.49%
2020-12-31NZ$0.89 B10.5%
2019-12-31NZ$0.80 B13.43%
2018-12-31NZ$0.71 B-3.55%
2017-12-31NZ$0.73 B124.42%
2016-12-31NZ$0.32 B69.41%
2015-12-31NZ$0.19 B40.37%
2014-12-31NZ$0.13 B5.74%
2013-12-31NZ$0.13 B8.09%
2012-12-31NZ$0.12 B86.42%
2011-12-31NZ$64.8 M-54.18%
2010-12-31NZ$0.14 B438.07%
2009-12-31NZ$26.28 M351.98%
2008-12-31NZ$5.81 M-2.24%
2007-12-31NZ$5.94 M